Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

GE HealthCare Recalls Nuclear Medicine 600/800 Series Systems for Risk of Detector Fall That May Injure Patients
February 23, 2023 — Editor's note: This news item has been updated to reflect that the FDA has since updated its alert to state that there have been no complaints reported related to the issue, that the issue was identified internally by GE HealthCare, and, while conduct
Nuclear Medicine Bone Scan Study Identifies Prevalence and Outcomes of Cardiac Amyloidosis
January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to…
World's First Digital SPECT/CT Capable of High Energy Imaging Enables Full Range of Clinical Capabilities to Nuclear Medicine Centers
October 18, 2022 — Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore …
Top 10: September's Most-read Content
Here is a recap of what ITN viewers found most interesting during the month of September:

1. Lasting Lung Damage Seen in Children and Teens after COVID
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions…

News | PET Imaging

Nuclidium and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNET in Neuroendocrine Tumors

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

March 24, 2023

A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very fine resolution has been developed and successfully tested, according to research published in the March issue of The Journal of Nuclear Medicine.

News | Nuclear Imaging

New Compact and Low-cost Lensless Radiomicroscope Developed for Nuclear Medicine Imaging

March 22, 2023 — A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very ...

March 22, 2023

Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical services, is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation

News | PET-CT

Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device

March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical ...

March 21, 2023

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP‑001

News | Contrast Media

New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care

March 9, 2023 — Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate ...

March 09, 2023

100-foot crane lifting Rhodotron TTE-300 HE Electron Beam Accelerator at NorthStar Medical Radioisotope's new Ac-225 Production facility in Beloit, Wisconsin (Photo: Business Wire)

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)

March 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

March 03, 2023

Novel manganese-based macrocyclic Magnetic Resonance Imaging (MRI) agent could offer an alternative to gadolinium-based agents

News | Contrast Media

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

March 2, 2023 — GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion ...

March 02, 2023

Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT solution - Philips Spectral Angio CT suite

News | SPECT-CT

Philips Announces New Milestones in the Development of the World’s First Spectral Detector Angio CT Solution

March 2, 2023 —Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT ...

March 02, 2023

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for somatostatin receptor (SSTR) PET imaging for patients with neuroendocrine tumors (NETs).

News | PET Imaging

Procedure Standard/practice Guideline Published for SSTR PET Imaging of Neuroendocrine Tumors

February 23, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of ...

February 23, 2023

First dosage administered at the Hospital of the University of Pennsylvania following FDA approval

News | Contrast Media

Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

February 16, 2023

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital in China

News | Radiation Therapy

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...

February 16, 2023

The FDA has identified this as a Class I recall, the most serious type of recall

News | Nuclear Imaging

GE HealthCare Recalls Nuclear Medicine 600/800 Series Systems for Risk of Detector Fall That May Injure Patients

February 23, 2023 — Editor's note: This news item has been updated to reflect that the FDA has since updated its alert ...

February 15, 2023

Requiring half the gadolinium dosage compared to other macrocyclic gadolinium-based contrast agents (GBCAs) in approved indications in the U.S., gadopiclenol also has the highest relaxivity compared to approved GBCAs1-7

News | Contrast Media

First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI

February 15, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

February 15, 2023

18F-rhPSMA-7.3 PET image showing multiple areas of uptake in the prostate gland in a man with newly diagnosed prostate cancer Photo courtesy of Blue Earth Diagnostics

News | Prostate Cancer

Blue Earth Diagnostics Highlights Upcoming Presentation of Additional Results from Investigational Phase 3 LIGHTHOUSE Study

February 9, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

February 09, 2023

Moffitt Cancer Center at International Plaza

News | Proton Therapy

IBA Announces Contract with Moffitt Cancer Center for a Proteus ONE Proton Therapy Solution

February 7, 2023 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, today announces ...

February 07, 2023

Summary of the pilot study and preliminary PET imaging findings. Image created by R Wetherill, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

News | PET Imaging

PET Imaging Shows Greater Lung Inflammation in e-cigarette Users than Cigarette Smokers

January 31, 2023 — Electronic cigarette (e-cigarette) users have greater lung inflammation than cigarette smokers and ...

January 31, 2023

Summary of imaging findings from the SEER-Medicare linked database for patients with non-small cell lung cancer prior to receiving subsequent radiation therapy. Image created by Emily Sterbis, MD, Interventional Radiology Resident at the University of Colorado

News | Lung Imaging

Nearly Half of Medicare Patients with Non-small Cell Lung Cancer not Staged According to National Guidelines

January 23, 2023 — A study published in the January issue of The Journal of Nuclear Medicine reports that approximately ...

January 23, 2023

ASNC releases comprehensive tool for assessing quality, setting meaningful goals, improving patient care in SPECT MPI laboratories

News | Cardiac Imaging

New Guide Will Change How Cardiac Imagers Approach Quality Improvement

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

January 13, 2023